Yu Zhou

Yu Zhou

Auto-generated profile, based on publicly available information

Yu Zhou

Department of Chemistry and State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Hong Kong SAR, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2020 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
YHYiran Huang
Yiran Huang
LMLing Meng
Ling Meng
QNQigui Nie
Qigui Nie
YZYu Zhou
Yu Zhou
LCLangdong Chen
Langdong Chen
XLXiaoyu Li
Xiaoyu Li

7 February 2024 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
YZYu Zhou
Yu Zhou
WSWenyin Shen
Wenyin Shen
YGYing Gao
Ying Gao
JPJianzhao Peng
Jianzhao Peng
QLQingrong Li
Qingrong Li
XLXiaoyu Li
Xiaoyu Li

22 August 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YHYiran Huang
Yiran Huang
RHRui Hou
Rui Hou
FLFong Sang Lam
Fong Sang Lam
YJYunxuan Jia
Yunxuan Jia
YZYu Zhou
Yu Zhou
XLXiaoyu Li
Xiaoyu Li

1 September 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YZYu Zhou
Yu Zhou
WSWenyin Shen
Wenyin Shen
JPJianzhao Peng
Jianzhao Peng
YDYuqing Deng
Yuqing Deng
XLXiaoyu Li
Xiaoyu Li

29 September 2026 in Molecular Pharmaceutics
Verified
Journal Article
Open access
XLXiaoyan Li
Xiaoyan Li
YWYu Yu Win
Yu Yu Win
YHYuan Hua
Yuan Hua
MAMuhammad Amir
Muhammad Amir
JMJason C. Mixdorf
Jason C. Mixdorf
WCWeibo Cai
Weibo Cai
Targeted imaging for the extracellular domain (ECD) of epidermal growth factor receptor (EGFR) is promising for early diagnosis and therapeutic applications toward cancers. Herein, we report the design of a γ-AApeptide-based antibody-like peptidomimetic as a radiotracer for EGFR-targeted positron emission tomography (PET) imaging. A dimeric cyclic γ-AApeptide (D1) was designed by dimerizing a previously reported EGFR-binding peptidomimetic ligand, resulting in a 6-fold enhancement in binding affinity (Kd = 0.11 μM) compared to its monomeric counterpart (M1, Kd = 0.67 μM). Both ligands were conjugated with chelators and radiolabeled with 64Cu to yield [64Cu]Cu-NOTA-M1 (monomer) and [64Cu]Cu-DOTA-D1 (dimer), respectively. In vivo PET imaging demonstrated that [64Cu]Cu-DOTA-D1 achieved significantly higher tumor uptake than [64Cu]Cu-NOTA-M1 in EGFR-positive tumor models (e.g., 10.83 ± 2.70 %ID/g vs 2.80 ± 0.72 %ID/g in U87 tumors at 4 h p.i.). Blocking and EGFR-negative control studies further confirmed the targeting specificity of [64Cu]Cu-DOTA-D1. Ex vivo biodistribution analysis showed consistent enhancement in tumor uptake (e.g., 7.94 ± 0.24 %ID/g vs 3.81 ± 0.44 %ID/g in U87 tumors at 48 h p.i.) for the dimeric tracer, accompanied by increased uptake in clearance organs. Overall, this work demonstrates that cyclic γ-AApeptides could serve as effective antibody-like peptidomimetics for EGFR targeting in vivo and provides a versatile strategy for developing peptidomimetic radiotracers for molecular imaging applications.

1 January 2024
Verified
Book Chapter
Closed access
PDF file
YZY. Zhou
Y. Zhou
YHY. Huang
Y. Huang
LXL. Xu
L. Xu
FXF. Xiong
F. Xiong
DNA-encoded chemical libraries (DELs) provide a powerful high-throughput screening platform that is used in both academia and industry. High-quality DELs lay the foundation for reliable DEL selection outcomes, and most pharmaceutical companies would prefer double-stranded DELs (dsDELs) because of their superior stability. Here, we summarize the experimental details for encoding a dsDEL, including the overall encoding strategy, synthetic chemistry of building-block addition, ligation strategies of code elongation, and quality control of the resulting libraries, exemplified with a 320-million-membered benzimidazole dsDEL from GlaxoSmithKline (GSK). We also briefly review the successful selection cases involving the presented libraries to highlight the great potential of dsDELs in drug discovery.